Search clinical trials for: FX 800 Dialyzer

Total 7236 results

Baxter Healthcare Corporation

Completed

Clinical Performance Comparison of 2 THERANOVA 400 Dialyzer Prototypes in HD With High-Flux Dialyzers in HD and hv HDF Mode

End Stage Renal Disease

Germany
Baxter Healthcare Corporation

Recruiting

Theranova Randomized, Controlled, Trial (RCT) in China

Acute Kidney Failure | Chronic Kidney Failure

China
Kyungpook National University Hospital
Baxter Healthcare Corporation; Kyungpook National University Chilgok Hospital; Yeungnam University Hospital and other collaborators

Completed

Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function (THREAD)

End Stage Renal Disease

Korea, Republic of
Baxter Healthcare Corporation

Completed

Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes With a High-Flux Dialyzer in Hemodialysis Mode

End Stage Renal Disease

Austria
University College, London

Completed

Clotting With Different Dialyzer Membranes (TAGPSOLACEA)

Kidney Failure
Medical University of Graz

Completed

Hs-Troponin T Kinetics in Patients Treated With MCO Membranes Compared to High-flux, Low-flux Membranes and HDF

Troponin T

Austria
National Taiwan University Hospital
Mrs. Hsiu-Chin Lee Kidney Research Fund

Unknown

High Flux Hemodialysis Thrice Versus Once

End-Stage Renal Disease

Taiwan
Réseau de Santé Vitalité Health Network

Unknown

Second Clinical Evaluation of THERANOVA-500 Dialyzer in Chronic Hemodialysis (HD)

End Stage Renal Disease on Dialysis

Canada
Sir Charles Gairdner Hospital

Completed

Short Term Effects of FX Dialysers on QOL and Inflammation

Kidney Failure, Chronic

Australia
University of Alberta
University of Calgary

Completed

Examining the Impact of Using Two Dialysers in Parallel on Dialysis Adequacy in Hemodialysis Patients

End Stage Renal Disease

Canada
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration

End Stage Renal Disease

China
Yungjin Pharm. Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

MELAS Syndrome | Mitochondrial Respiratory Chain Deficiencies

Korea, Republic of
JMackem Co., Ltd
Seoul National University Hospital

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Diabetic Neuropathies | Neuropathic Pain | Post Herpetic Neuralgia

Korea, Republic of
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

Influenza

China
Baxter Healthcare Corporation

Completed

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

End Stage Renal Disease

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers

Asthma; Allergic Rhinitis

China
Poitiers University Hospital
Baxter Healthcare Corporation

Completed

Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer (THERANOVA)

End Stage Renal Disease | Dialysis Related Complication | Dialysis Amyloidosis

France
Ilkos Therapeutic Inc.

Completed

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Venous Leg Ulcer

Spain, Hungary, Canada, United States, Brazil, Argentina, Austria, Czechia, Italy, Poland, Slovakia
Gannex Pharma Co., Ltd.
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Baxter Healthcare Corporation
German Federal Ministry of Education and Research; Gambro Dialysatoren GmbH

Completed

PERCI- Medium Cut Off (MCO) (PERCI-MCO)

Chronic Inflammation | Chronic Kidney Failure

Germany
Baxter Healthcare Corporation

Completed

Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration

End Stage Renal Disease

Spain
CymaBay Therapeutics, Inc.

Completed

Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406

Healthy Volunteers

Australia
Ridgeback Biotherapeutics, LP
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19

SARS-CoV-2 Infection, COVID-19

United States
Merck Sharp & Dohme LLC

Completed

A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)

Hepatitis C Virus Infection
Poitiers University Hospital
Hemotech

Completed

Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers (E-FLUX)

End Stage Renal Disease (ESRD)

France
CVI Pharmaceuticals

Unknown

Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia

Hyperlipidemia

China
Hospital Clinic of Barcelona
Fresenius Medical Care Deutschland GmbH

Completed

Comparison FX CorDiax 60 in Relation to the FX 60-Dialyzer

Hemodialysis

Spain
Frequency Therapeutics

Completed

FX-322 in Adults With Stable Sensorineural Hearing Loss

Sensorineural Hearing Loss | Noise Induced Hearing Loss | Sudden Sensorineural Hearing Loss

United States
Pfizer

Completed

An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy

Familial Amyloid Polyneuropathy | ATTR-PN

Sweden, Brazil, Germany, Argentina, France, Portugal
St. Louis University

Completed

PFA-100 Responsive to Effect of Energy Drinks on Platelet Function

Thrombosis | Platelet Function

United States
Pfizer

Withdrawn

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

Ulcerative Colitis

United States
The University of Hong Kong
Baxter Healthcare Corporation

Completed

Theranova vs High-flux HD Comparison

End Stage Renal Failure on Dialysis

Hong Kong
Carlo Maria Guastoni

Unknown

Effect of a Medium Cut-Off Dialyzer - Medical Device on ESA Resistance in 110 Hemodialysis Patients (EXPAND) (EXPAND)

Hemodialysis Complication
Royal Free Hampstead NHS Trust

Completed

Study to Assess Clearances and Bio-compatibility of ELISIO Dialyzer

Chronic Kidney Disease

United Kingdom
Pfizer

Completed

The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy

Cardiomyopathy

United States
Pfizer

Completed

Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction

Mild Hepatic Dysfunction | Moderate Hepatic Dysfunction

South Africa
Kantonsspital Aarau
Fresenius Medical Care Deutschland GmbH

Completed

Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser

Renal Failure Chronic Requiring Hemodialysis

Switzerland
GlaxoSmithKline

Completed

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

Psoriasis

Germany, United Kingdom
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Influenza A

China
Fresenius Medical Care Deutschland GmbH

Completed

Comparative Safety and Clinical Performance of Dialyzers Applied During Post-dilution Online Hemodiafiltration (eMPORA II)

Renal Failure | End Stage Renal Disease

Germany
Fresenius Medical Care Deutschland GmbH

Completed

Safety and Clinical Performance of a Dialyzer With a Modified Polysulfone Membrane (eMPORA)

Renal Failure | End Stage Renal Disease

Germany
Lexicon Pharmaceuticals

Completed

A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Shape Memory Medical, Inc.

Active, not recruiting

Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks (AAA-SHAPE)

Abdominal Aortic Aneurysm

New Zealand
Ascentage Pharma Group Inc.

Recruiting

APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia (MAPLE-1)

Waldenstrom Macroglobulinemia

United States, China, Australia
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer

Lung Cancer

United States, Canada
Frequency Therapeutics

Terminated

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

Hearing Loss, Sensorineural

United States
Frequency Therapeutics

Completed

FX-322 in Adults With Acquired Sensorineural Hearing Loss

Hearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing Loss

United States
Flare Therapeutics Inc.

Recruiting

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Advanced Solid Tumors Cancer | Advanced Urothelial Carcinoma | Open Label | Oral Drug Administration

United States

Search clinical trials for: FX 800 Dialyzer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations